Published in J Pain Symptom Manage on February 06, 2008
Fentanyl for the treatment of tumor-related breakthrough pain. Dtsch Arztebl Int (2013) 1.81
Considerations in selecting rapid-onset opioids for the management of breakthrough pain. J Pain Res (2013) 0.92
Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group. Support Care Cancer (2015) 0.85
Role of intranasal fentanyl in breakthrough pain management in cancer patients. Cancer Manag Res (2010) 0.78
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting. Support Care Cancer (2013) 0.77
A fixed inhaled nitrous oxide/oxygen mixture as an analgesic for adult cancer patients with breakthrough pain: study protocol for a randomized controlled trial. Trials (2017) 0.75
A randomized controlled trial comparing the effect of intravenous, subcutaneous, and intranasal fentanyl for pain management in patients undergoing cesarean section. Adv Biomed Res (2016) 0.75
A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet. J Pain Res (2008) 0.75
[Questions from a pain physician reader: Evidence, empiricism, eminence - all the same?]. Schmerz (2013) 0.75
[Rapid release fentanyl administration forms. Comments of the Working Group on Tumor Pain of the German Pain Society]. Schmerz (2013) 0.75